An epitope-specific novel anti-EMMPRIN polyclonal antibody inhibits tumor progression.

Walter, Miriam; Simanovich, Elina; Brod, Vera; Lahat, Nitza; Bitterman, Haim; Rahat, Michal A

Walter, Miriam; Simanovich, Elina; Brod, Vera; Lahat, Nitza; Bitterman, Haim; Rahat, Michal A.

Afiliación

Walter M; Immunology Research Unit, Carmel Medical Center , Haifa, Israel.
Simanovich E; Immunology Research Unit, Carmel Medical Center , Haifa, Israel.
Brod V; Ischemia-shock Research Laboratory, Carmel Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine , Technion, Haifa, Israel.
Lahat N; Immunology Research Unit, Carmel Medical Center , Haifa, Israel.
Bitterman H; Ischemia-shock Research Laboratory, Carmel Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine , Technion, Haifa, Israel.
Rahat MA; Immunology Research Unit, Carmel Medical Center , Haifa, Israel.

Oncoimmunology ; 5(2): e1078056, 2016 Feb.

Article en En | MEDLINE | ID: mdl-27057452

Palabras clave

ADCC; MMP-9; VEGF; angiogenesis; anti-EMMPRIN/CD147; apoptosis; tumor cellmacrophage interactions; tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google